3 Questions About JAK Inhibitors for Severe Alopecia Areata

Ask how the proposed medicine fits your extent of hair loss and your health history.

Three questions for the treatment discussion

1. Why this medicine for my hair loss? The treatment plan considers how much hair has been lost, where, for how long and your age. Some JAK inhibitors are approved for adults with severe alopecia areata; approval details differ between drugs. Ask which option is proposed and what response would count as useful progress.¹

2. Which risks matter for my history? Tell the dermatologist about smoking, previous clots or cardiovascular disease, cancer, shingles and other health conditions. Serious infections and blood clots are among possible serious adverse effects. Bring your medicine and supplement list so interactions can be reviewed.²

3. How will we monitor benefit and safety? The dermatologist will monitor whether the treatment is working and whether it should continue. Ask for the appointment schedule, any required laboratory testing and the symptoms you should report between visits. The plan needs to be specific to the prescribed medicine.²

Read the warning in the context of the drug

Some class warnings reflect safety findings from a different JAK inhibitor. That does not make the warning irrelevant. Ask the dermatologist to explain the evidence for your proposed drug and how your circumstances affect the decision.²

Write down the agreed goal

Record the medicine name, follow-up date and the outcome you want to discuss at that visit. Ask how the clinician plans to compare your progress over time.

Hair, Everywhere lists a monthly Hair Log and a visit script in its toolkit. They can help organize observations and appointment questions. See the book.